Andre Hoekema

Andre Hoekema is currently the Chairman at Artax Biopharma, Inc. He is also a Non-Executive Director at Mimetas BV, a Director at Sapreme Technologies BV, and a Member-Supervisory Board at Fibrocor Therapeutics LP.
In his former positions, Dr. Hoekema served as the Managing Director of Corporate Development at Invitrogen Corp., the Director of Business Development at Crucell NV, and the Managing Director of Molecular Probes Europe BV.
He also worked as a Research & Development Officer at Genentech, Inc. and as the Senior Vice President of Corporate Development at Galapagos NV.
Additionally, he held positions such as Head of Research & Project Management at Mogen International Nv, Research & Project Management Officer at DSM Life Sciences Products, and Head of Research & Project Management at Syngenta Mogen BV.
He was also a Member-Supervisory Board at VitalneXt BV.
Dr. Hoekema obtained a doctorate degree from the University of Leiden.